FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to therapy and infectious diseases, and concerns a method of detecting vascular endothelium involvement. Method for detecting vascular endothelium involvement, comprising determining the number of circulating endothelial cells and activated thrombocytes in the blood of patients by sequential gating, where counting of circulating endothelial cells is carried out by fractions CD45-CD31+CD42b-, and counting of activated thrombocytes - CD45-CD31+CD42b+, and by number of circulating endothelial cells and activated thrombocytes damage of vascular endothelium is detected. Number of CD45-CD31+CD42b- events defined as circulating endothelial cells in patients is 562.17 ± 415.95 in mcl against 4.69 ± 1.48 mcl in healthy people; and the number of CD45-CD31+CD42b + events defined as activated thrombocytes in patients is 1139.20 ± 152.15 in mcl versus 7.65 ± 2.47 in mcl in healthy individuals.
EFFECT: method enables detecting vascular endothelium involvement and, consequently, starting the therapy aimed at correcting the pathological process, as well as assessing the effectiveness of the applied therapy.
1 cl, 5 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIAGNOSING IN-STENT RESTENOSIS | 2014 |
|
RU2566287C1 |
METHOD FOR DETERMINING COMPLEMENT-ACTIVATING FUNCTION OF SARS-CoV-2 ANTIBODIES FOR PREDICTING SEVERITY OF COVID-19 | 2023 |
|
RU2818351C1 |
METHOD FOR DETERMINING THE DEGREE OF RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN COVID-19 | 2021 |
|
RU2768575C1 |
METHOD OF PREDICTING SEVERITY OF SYSTEMIC INFLAMMATORY RESPONSE IN HUMAN BODY IN DISEASES | 2022 |
|
RU2808416C1 |
METHOD FOR FUNCTIONAL AND QUANTITATIVE EVALUATION OF PLATELET-MONOCYTIC COMPLEXES IN WHOLE PERIPHERAL BLOOD SAMPLES | 2020 |
|
RU2762820C1 |
METHOD OF SEVERITY ASSESSMENT FOR HEMORRHAGIC FEVER WITH RENAL SYNDROME | 2009 |
|
RU2392858C1 |
METHOD FOR PREDICTING RISK OF DEATH AT HOSPITAL STAGE IN PATIENTS WITHOUT ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION WHO HAVE UNDERGONE NEW COVID-19 CORONAVIRUS INFECTION, TAKING INTO ACCOUNT THEIR IMMUNOLOGICAL STATUS | 2022 |
|
RU2781565C1 |
METHOD OF DETECTION OF CELL-FREE DNA IN WHOLE PERIPHERAL BLOOD USING FLOW CYTOMETRY | 2022 |
|
RU2815709C1 |
METHOD FOR PREDICTION OF RISK OF CARDIOVASCULAR MORTALITY IN PATIENTS SUFFERING FROM CHRONIC ISCHEMIC HEART FAILURE COMBINED WITH TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2531947C1 |
METHOD OF DETERMINING COMPOSITION OF INDIVIDUAL EXTRACELLULAR VESICLES IN HUMAN BLOOD | 2014 |
|
RU2583940C1 |
Authors
Dates
2022-03-15—Published
2021-03-03—Filed